Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal
Hanmi Pharmaceutical has licensed its novel drug candidate sonefpeglutide to global pharmaceutical giant Eli Lilly and Company in a deal valued at up...
Search results for "obesity treatment"
The Art of Healthy Aging: What Youn Yuh-jung and Paul McCartney Teach Us About Staying Sharp
Academy Award-winning actress Youn Yuh-jung, 79, is frequently celebrated as a global symbol of natural aging and sustained, vibrant engagement with...
High Blood Pressure After Childbirth: Why the Cardiovascular Risks of Preeclampsia Don't End at Delivery
"They told me my blood pressure was a bit high during pregnancy, but doesn’t it go back to normal after I give birth.
Robotic Gallbladder Surgery Flourishes Regionally: On Hospital’s Kim Geon-guk Surpasses 200 Cases in a Single Year
Surgery for cholecystitis or gallstones is no longer the exclusive domain of major university hospitals.
Is High Blood Pressure a "Men’s Disease"? Debunking Common Myths for World Hypertension Day
High blood pressure is identified by the World Health Organization as the leading global risk factor for death.
Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection
Daewoong Pharmaceutical is teaming up with a biotech startup to develop an obesity treatment administered by injection...
GLP-1 Weight-Loss Drugs: Potential Metabolic Instability Linked to Long-Term Use
A new study suggests that the long-term administration of GLP-1 receptor agonists—the class of anti-obesity medications...
Lost 3 kg in Just One Week? What Happens When You Cut Carbs
What is the most suitable fuel for the human body? The answer involves complex biochemistry, but a basic understanding...
Taking Wegovy or Mounjaro? Seek Immediate Medical Attention if ‘These Symptoms’ Appear
As anti-obesity medications for weight loss and blood sugar control gain popularity, monitoring and managing potential...
Resistance in the Genes: Why Popular Obesity Drugs Don’t Work for Everyone
GLP-1 receptor agonists like Wegovy and Mounjaro have fundamentally reshaped the treatment of diabetes and obesity.